Rosiglitazone and pioglitazone increase fracture risk in women and men with type 2 diabetes.

Aubert, R E

Rosiglitazone and pioglitazone increase fracture risk in women and men with type 2 diabetes. [electronic resource] - Diabetes, obesity & metabolism Aug 2010 - 716-21 p. digital

Publication Type: Journal Article

1463-1326

10.1111/j.1463-1326.2010.01225.x doi


Adult
Diabetes Mellitus, Type 2--complications
Female
Fractures, Bone--chemically induced
Humans
Hypoglycemic Agents--adverse effects
Incidence
Male
Middle Aged
Pioglitazone
Risk Factors
Rosiglitazone
Thiazolidinediones--adverse effects
Treatment Outcome